The Scientist

» melanoma, disease/medicine and immunology

Most Recent

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: GM Mosquitoes Reduce Dengue Cases in Brazil

GM Mosquitoes Reduce Dengue Cases in Brazil

By | July 18, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

2 Comments

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

2 Comments

image: “Redhead” Gene Variant Boosts Melanoma Risk

“Redhead” Gene Variant Boosts Melanoma Risk

By | July 12, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

1 Comment

image: How High Fat and Insulin Levels May Lead to Diabetes

How High Fat and Insulin Levels May Lead to Diabetes

By | July 1, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Immune Cell–Stem Cell Cooperation

Immune Cell–Stem Cell Cooperation

By , and | July 1, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

1 Comment

image: What Causes Type 2 Diabetes?

What Causes Type 2 Diabetes?

By | July 1, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

9 Comments

image: Immune Cells' Role in Tissue Maintenance and Repair

Immune Cells' Role in Tissue Maintenance and Repair

By , and | July 1, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Zika and Dengue Immunity: A Complex Relationship

Zika and Dengue Immunity: A Complex Relationship

By | June 28, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech